Thursday, March 19, 2009

Numerate Raises $5.5M

San Bruno-based Numerate, a biotech firm developing small molecule therapeutics, said Wednesday that it has raised $5.5M in a Series B funding. The company said that Foundation Capital led the round, which also included Lanza techVentures. Numerate is developing a computationally-based, drug design process which looks to cut the time required to deliver potential clinical drug candidates. More information »